vs
Bionano Genomics, Inc.（BNGO）与RIVERVIEW BANCORP INC（RVSB）财务数据对比。点击上方公司名可切换其他公司
RIVERVIEW BANCORP INC的季度营收约是Bionano Genomics, Inc.的1.8倍（$14.0M vs $8.0M），RIVERVIEW BANCORP INC净利率更高（9.8% vs -99.8%，领先109.6%），RIVERVIEW BANCORP INC同比增速更快（10.4% vs -2.6%），过去两年RIVERVIEW BANCORP INC的营收复合增速更高（24.6% vs -4.8%）
Bionano Genomics是一家基因组技术企业，开发并销售专有光学基因组测绘技术及相关诊断解决方案，可高精度检测基因组大型结构变异，服务全球学术研究机构、生物制药企业与临床诊断实验室，产品应用于肿瘤、罕见病研究等领域。
Riverview Bancorp Inc.是一家总部位于美国的银行控股公司，主营个人与商业银行业务，服务覆盖太平洋西北地区，提供存款、消费贷款、住房抵押贷款、商业信贷及小企业金融等产品，服务零售客户与本地企业群体。
BNGO vs RVSB — 直观对比
营收规模更大
RVSB
是对方的1.8倍
$8.0M
营收增速更快
RVSB
高出13.0%
-2.6%
净利率更高
RVSB
高出109.6%
-99.8%
两年增速更快
RVSB
近两年复合增速
-4.8%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $8.0M | $14.0M |
| 净利润 | $-7.9M | $1.4M |
| 毛利率 | 42.8% | — |
| 营业利润率 | -107.4% | 12.4% |
| 净利率 | -99.8% | 9.8% |
| 营收同比 | -2.6% | 10.4% |
| 净利润同比 | 60.6% | 11.8% |
| 每股收益（稀释后） | $-0.12 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BNGORVSB
| Q4 25 | $8.0M | $14.0M | ||
| Q3 25 | $7.4M | $13.6M | ||
| Q2 25 | $6.7M | $13.3M | ||
| Q1 25 | $6.5M | $12.9M | ||
| Q4 24 | $8.2M | $12.7M | ||
| Q3 24 | $6.1M | $12.8M | ||
| Q2 24 | $7.8M | $12.2M | ||
| Q1 24 | $8.8M | $9.0M |
净利润BNGORVSB
| Q4 25 | $-7.9M | $1.4M | ||
| Q3 25 | $-8.5M | $1.1M | ||
| Q2 25 | $-6.9M | $1.2M | ||
| Q1 25 | $-3.1M | $1.1M | ||
| Q4 24 | $-20.1M | $1.2M | ||
| Q3 24 | $-44.2M | $1.6M | ||
| Q2 24 | $-16.2M | $966.0K | ||
| Q1 24 | $-31.4M | $-3.0M |
毛利率BNGORVSB
| Q4 25 | 42.8% | — | ||
| Q3 25 | 45.7% | — | ||
| Q2 25 | 51.6% | — | ||
| Q1 25 | 45.5% | — | ||
| Q4 24 | 41.9% | — | ||
| Q3 24 | -139.1% | — | ||
| Q2 24 | 33.3% | — | ||
| Q1 24 | 32.2% | — |
营业利润率BNGORVSB
| Q4 25 | -107.4% | 12.4% | ||
| Q3 25 | -115.9% | 10.2% | ||
| Q2 25 | -115.8% | 11.7% | ||
| Q1 25 | -131.1% | 11.3% | ||
| Q4 24 | -146.3% | 12.4% | ||
| Q3 24 | -722.9% | 15.5% | ||
| Q2 24 | -219.0% | 10.0% | ||
| Q1 24 | -354.9% | -47.5% |
净利率BNGORVSB
| Q4 25 | -99.8% | 9.8% | ||
| Q3 25 | -115.4% | 8.1% | ||
| Q2 25 | -101.8% | 9.2% | ||
| Q1 25 | -48.0% | 8.9% | ||
| Q4 24 | -246.5% | 9.7% | ||
| Q3 24 | -728.6% | 12.2% | ||
| Q2 24 | -208.8% | 7.9% | ||
| Q1 24 | -358.3% | -34.7% |
每股收益（稀释后）BNGORVSB
| Q4 25 | $-0.12 | $0.07 | ||
| Q3 25 | $-1.59 | $0.05 | ||
| Q2 25 | $-1.99 | $0.06 | ||
| Q1 25 | $-1.15 | $0.05 | ||
| Q4 24 | $-7.05 | $0.06 | ||
| Q3 24 | $-30.92 | $0.07 | ||
| Q2 24 | $-14.41 | $0.05 | ||
| Q1 24 | $-35.75 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.0M | $28.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $44.4M | $164.2M |
| 总资产 | $73.6M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BNGORVSB
| Q4 25 | $3.0M | $28.6M | ||
| Q3 25 | $3.1M | $32.8M | ||
| Q2 25 | $3.6M | $34.2M | ||
| Q1 25 | $3.6M | $29.4M | ||
| Q4 24 | $9.2M | $25.3M | ||
| Q3 24 | $8.8M | $31.0M | ||
| Q2 24 | $10.4M | $27.8M | ||
| Q1 24 | $15.8M | $23.6M |
股东权益BNGORVSB
| Q4 25 | $44.4M | $164.2M | ||
| Q3 25 | $49.8M | $163.5M | ||
| Q2 25 | $45.4M | $162.0M | ||
| Q1 25 | $48.2M | $160.0M | ||
| Q4 24 | $35.4M | $158.3M | ||
| Q3 24 | $48.9M | $160.8M | ||
| Q2 24 | $80.3M | $155.9M | ||
| Q1 24 | $82.8M | $155.6M |
总资产BNGORVSB
| Q4 25 | $73.6M | $1.5B | ||
| Q3 25 | $79.1M | $1.5B | ||
| Q2 25 | $76.0M | $1.5B | ||
| Q1 25 | $78.4M | $1.5B | ||
| Q4 24 | $76.7M | $1.5B | ||
| Q3 24 | $87.4M | $1.5B | ||
| Q2 24 | $129.4M | $1.5B | ||
| Q1 24 | $158.0M | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.2M | $-506.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-736.0K |
| 自由现金流率自由现金流/营收 | — | -5.2% |
| 资本支出强度资本支出/营收 | — | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.37× |
| 过去12个月自由现金流最近4个季度 | — | $20.4M |
8季度趋势，按日历期对齐
经营现金流BNGORVSB
| Q4 25 | $-4.2M | $-506.0K | ||
| Q3 25 | $-5.9M | $16.8M | ||
| Q2 25 | $-3.5M | $-697.0K | ||
| Q1 25 | $-2.8M | $8.3M | ||
| Q4 24 | $-6.5M | $2.2M | ||
| Q3 24 | $-13.3M | $764.0K | ||
| Q2 24 | $-21.0M | $5.4M | ||
| Q1 24 | $-28.1M | $12.8M |
自由现金流BNGORVSB
| Q4 25 | — | $-736.0K | ||
| Q3 25 | — | $16.4M | ||
| Q2 25 | — | $-773.0K | ||
| Q1 25 | — | $5.6M | ||
| Q4 24 | — | $1.9M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $5.3M | ||
| Q1 24 | — | $7.1M |
自由现金流率BNGORVSB
| Q4 25 | — | -5.2% | ||
| Q3 25 | — | 120.1% | ||
| Q2 25 | — | -5.8% | ||
| Q1 25 | — | 43.1% | ||
| Q4 24 | — | 15.0% | ||
| Q3 24 | — | -11.3% | ||
| Q2 24 | — | 43.7% | ||
| Q1 24 | — | 79.0% |
资本支出强度BNGORVSB
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 21.0% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | 17.3% | ||
| Q2 24 | — | 0.9% | ||
| Q1 24 | — | 62.0% |
现金转化率BNGORVSB
| Q4 25 | — | -0.37× | ||
| Q3 25 | — | 15.25× | ||
| Q2 25 | — | -0.57× | ||
| Q1 25 | — | 7.20× | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | — | 0.49× | ||
| Q2 24 | — | 5.63× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
